Appropriate use of remdesivir in patients with COVID-19 who are on hemodialysis may not result in a high risk of side effects, such as hepatotoxicity, according to investigators.
Both potassium binders effectively lowered serum potassium levels in patients on hemodialysis meeting hyperkalemia definitions, compared with no treatment, investigators reported.
Incremental hemodialysis appears as safe as conventional hemodialysis with respect to death risk in appropriately selected patients, with data from randomized controlled trials suggesting that incremental hemodialysis reduced the likelihood of hospitalization.
Particulate matter, one of the major air pollutants, is increasingly linked with adverse health outcomes, including in patients with chronic kidney disease.
Suboptimal management of myocardial infarction in patients with kidney failure may be a key modifiable cause of the worse prognosis, according to investigators.
According to investigators, clinicians need to weigh the antimicrobial benefits of azithromycin, levofloxacin, and amoxicillin-based antibiotics against their potential cardiac risks in the hemodialysis population.
